Editorial Board


Jivaro Journal is led by an editorial team responsible for maintaining the journal’s scholarly standards, editorial process, and peer-review integrity. The journal’s editors and board members bring experience across finance, science and health, technology, policy, design, and international industry practice.


Editorial Leadership

Harry Negron

FOUNDING EDITOR / EDITOR-IN-CHIEF

Jivaro CEO

Harry Negron serves as the Founding Editor and Editor-in-Chief of Jivaro Journal and is responsible for the journal’s editorial direction, publication standards, peer-review oversight, and final publication decisions.


Editorial Board

The Editorial Board supports the journal’s scope development, peer-review standards, reviewer identification, and subject-matter evaluation across the journal’s core areas.

Aiko Shimizu

EDITORIAL BOARD MEMBER

Dr. Aiko Shimizu reviews manuscripts at the intersection of medical science, imaging research, and artificial intelligence. Her expertise includes diagnostic model evaluation, clinical data interpretation, imaging-based biomarkers, and the responsible use of machine learning in healthcare settings. She is particularly attentive to study design, dataset quality, validation methods, and whether computational findings are presented with appropriate clinical context. Her review approach emphasizes methodological clarity, reproducibility, and practical relevance to patient-centered medical research.

Kenji Watanabe

EDITORIAL BOARD MEMBER

Dr. Kenji Watanabe reviews manuscripts in regenerative medicine, stem cell biology, aging-related biomedical research, and clinically oriented surgical science. His expertise is particularly useful for evaluating studies involving cell-based therapies, tissue repair mechanisms, and emerging biomedical interventions. He brings a senior scientific perspective to the review process, with strong attention to biological plausibility, ethical considerations, translational value, and the long-term significance of research findings. His reviews are especially suited to work that connects experimental discovery with future clinical application.

Reina Kondo

EDITORIAL BOARD MEMBER

Dr. Reina Kondo reviews research in environmental microbiology, ecosystem health, and climate-related biological change. Her background includes microbial community analysis, marine and coastal ecosystem studies, and interdisciplinary research connecting environmental conditions with broader public health and sustainability concerns. She places strong emphasis on sampling design, ecological interpretation, statistical transparency, and the appropriate framing of environmental findings. Her reviews are especially valuable for manuscripts that connect natural science evidence with real-world environmental and biological systems.

Michiko Arai

EDITORIAL BOARD MEMBER

Dr. Michiko Arai reviews manuscripts in immunology, infectious disease biology, and molecular medicine. Her expertise includes host immune responses, inflammatory pathways, experimental biomedical models, and translational research with potential clinical implications. She is especially focused on whether authors clearly connect laboratory findings to biological mechanisms and medical relevance. Her review style is rigorous and detail-oriented, with careful attention to experimental controls, ethical standards, interpretation of results, and the clarity of scientific communication.

Tatsuya Nakamura

EDITORIAL BOARD MEMBER

Dr. Tatsuya Nakamura reviews submissions involving biomedical engineering, biosensor development, nanomaterials, and applied medical technology. His expertise is especially relevant for manuscripts that combine engineering methods with biological or clinical applications. He focuses on whether technical claims are supported by appropriate validation, whether device performance is measured under meaningful conditions, and whether results are reproducible across experimental settings. His reviews emphasize practical design logic, data reliability, and the responsible translation of engineering innovation into biomedical use.

All editorial board appointments are made by the journal’s editorial leadership. Board composition may evolve as the journal develops its section coverage, reviewer network, and publication program.

Harry Negron

CEO of Jivaro, a writer, and a military vet with a PhD in Biomedical Sciences and a BS in Microbiology & Mathematics.

Previous
Previous

Peer Review Process

Next
Next

Aim & Scope